An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia

The American Journal of Medicine
J J TwomeyG Goldstein

Abstract

Serum from 21 patients with lymphoblastic leukemia, five with myeloblastic leukemia and 30 age matched control subjects tested for thymic hormone activity in an assay that measures the induction of T cell surface antigen. This activity was subnormal in serum from 10 of 16 patients with untreated lymphoblastic leukemia (p less than 0.001) but was within the normal range when the leukemia was in remission. Low inductive activity was associated with an inhibitor of T cell induction which was less than 30,000 daltons in molecular size and interfered with induction by purified thymopoietin plus a high concentration of ubiquitin or by normal serum alone.

References

Jul 1, 1978·The Journal of Clinical Endocrinology and Metabolism·V M LewisR A Good
Jun 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J J TwomeyR A Good
Dec 1, 1977·Cellular Immunology·G E Roelants, K S Mayor-Withey
Apr 1, 1979·The American Journal of Medicine·J J TwomeyR A Good
Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·G GoldsteinE A Boyse
Dec 1, 1975·Cellular Immunology·R S Basch, G Goldstein
Aug 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·A DeclèveH S Kaplan
Sep 1, 1964·The Journal of Experimental Medicine·A E REIF, J M ALLEN

❮ Previous
Next ❯

Citations

May 6, 1999·The Journal of Pediatrics·B U LiJ R Hayes
Jan 1, 1985·Critical Reviews in Oncology/hematology·R S Schulof

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
J J TwomeyR A Good
Polskie Archiwum Medycyny Wewnętrznej
L BergierA Zduńczyk
© 2021 Meta ULC. All rights reserved